Medtronic, Inc. beat street's prediction of 88 cents per share earnings with actual earnings of 90 cents per share. The company boasts its first $4 billion sales quarter in company history - a 10 percent increase over fourth quarter revenue this time last year - according to its fourth-quarter financial results for the fiscal year ending April 30.

The medical technology company reported a full-year revenue of $15.8 billion, which is an 8 percent increase from 2009's fiscal year revenue. The company's full year non-GAAP diluted earnings per share (EPS) of $3.22 increased by 10 percent and GAAP diluted (EPS) of $2.79 grew by 52 percent.

Internationally, Medtronic's revenue increased by 15 percent over 2009 fiscal year, to $6.451 billion. During the current fiscal year, international revenue represented 41 percent of the company's total revenue, according to the report.

The company predicts a revenue growth between 5 and 8 percent on a constant currency basis for 2011 fiscal year.

"We have a number of exciting new therapies we are preparing to launch in fiscal 2011, which will further solidify our leadership position in the markets we serve," said William Hawkins, chairman and CEO, in a company statement.

More Voices